| Name | Title | Contact Details |
|---|---|---|
Peter Wang |
Chief Technology Officer | Profile |
WellBe Senior Medical specializes in caring for patients with complex, chronic conditions, whose health is changing with age. As geriatric specialists, we have decades of experience serving these patients. We are committed to providing personal, Complete Care™ at home or anywhere our patients are, and our care team works together with patients, caregivers and physicians to nurture all aspects of health. The care we provide is sponsored by health plans and free to our patients.
Renue Physical Therapy was established in the Fall of 2011 with one clinic on Bay Road in Saginaw. Our goal from the start was to create a fully patient-focused practice model. We take pride in offering one-on-one treatment with the same therapy team throughout the course of therapy, providing a customized plan that is specific to your needs to help you achieve the best possible outcomes. Since our start in 2011, Renue has grown to more than 12 clinics serving the Great Lakes Bay Region and beyond, with locations in Auburn, Au Gres, Bay City, Bridgeport, Caro, Freeland, Midland, Saginaw and Shields.
Community Eldercare Services, LLC is a Tupelo, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Semper Laser is a laser hair removal company that specializes in providing affordable and advanced laser hair removal treatments for both men and women.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.